News from sanofi us A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( EuronextParis:SAN,NYSE:SNY)

Aug 13, 2014, 17:00 ET
Sanofi Pasteur Logo (PRNewsFoto/Sanofi Pasteur)

Sanofi Pasteur Announces Publication of Positive Data for Fluzone® High-Dose Vaccine in The New England Journal of Medicine

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that The New England Journal of Medicine published...

Aug 12, 2014, 08:50 ET
Colorectal Cancer: Early Diagnosis is Key (PRNewsFoto/Sanofi US)

Sanofi Launches Authorized Generic Version of Eloxatin® (oxaliplatin injection)

 Sanofi US announced today that it has launched an authorized generic version of Eloxatin® (oxaliplatin injection) through Winthrop US,...

Aug 11, 2014, 07:00 ET

Sanofi and MannKind Announce Global Licensing Agreement for Afrezza® (insulin human) Rapid-Acting Inhaled Insulin

Sanofi (EURONEXT: SAN and NYSE: SNY) and MannKind Corporation (Nasdaq: MNKD) announced today that they have entered into a worldwide exclusive...

Aug 05, 2014, 12:28 ET
Sanofi logo.  (PRNewsFoto/Sanofi)

Sanofi: Solid Sales and Business EPS Growth at CER

 Sanofi (NYSE: SNY; EURONEXT: SAN)   Q2 2014 Change (reported) Change (CER) Net...

Jul 31, 2014, 08:00 ET
Sanofi logo.  (PRNewsFoto/Sanofi)

Sanofi: Solid Sales and Business EPS Growth at CER

 Sanofi (NYSE: SNY; EURONEXT: SAN)   Q2 2014 Change (reported) Change (CER) Net...

Jul 31, 2014, 02:28 ET

Sanofi H1 2014 Results - Interview with Chris Viehbacher

Sanofi, a global and diversified healthcare leader, reports results for the first half of 2014. Chris Viehbacher, CEO of Sanofi, comments on...

Jul 31, 2014, 02:25 ET

Sanofi - Résultats T2 2014 - Interview du Directeur Général Chris Viehbacher

Sanofi, un leader mondial et diversifié de la santé, publie ses résultats pour le premier semestre 2014. Le Directeur...

Jul 30, 2014, 08:00 ET

Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia

Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that nine new Phase 3 ODYSSEY trials of...

Jul 22, 2014, 08:45 ET
Sanofi Pasteur Logo (PRNewsFoto/Sanofi Pasteur)

Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the first lots of Fluzone® (Influenza...

Jul 08, 2014, 08:01 ET

FDA Accepts Sanofi's New Drug Application for Basal Insulin Toujeo®

 Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the...

Jun 30, 2014, 10:00 ET

Kids at risk of severe allergies attend soccer clinic hosted by the Montreal Impact and Allerject™

MONTREAL, June 30, 2014 /CNW Telbec/ - For more than 75 youngsters with life-threatening allergies, participating in a soccer clinic hosted by...

Jun 14, 2014, 13:02 ET

Sanofi Reports Positive Phase 3 Results for Toujeo® (insulin glargine [rDNA origin] injection, 300 U/mL)

Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that, in a pooled analysis, investigational therapy Toujeo® (insulin glargine [rDNA...

Jun 14, 2014, 13:02 ET

Patients Continuing On Sanofi's Lantus® Had Lower Blood Sugar Levels Than Those who Switched to Insulin Detemir

Sanofi US announced today results from a real world outcome study of type 2 diabetes (T2D) patients that show switching from Lantus® (insulin...

Jun 14, 2014, 13:02 ET

Sanofi's Lyxumia® (lixisenatide) Showed More Pronounced After-Test-Meal Blood Sugar Lowering than Liraglutide when Both were Added to Insulin Glargine

 Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that Lyxumia® (lixisenatide) met the primary endpoint in an 8-week head-to-head...

Jun 14, 2014, 13:01 ET
Cities for Life helps improve diabetes management. (PRNewsFoto/Sanofi US)

Cities for Life Increased Community Support and Showed Improved Clinical Measures for People Living With or At Risk for Type 2 Diabetes

The American Academy of Family Physicians Foundation announced today that the Cities for Life program, supported by Sanofi US, helped decrease...

May 19, 2014, 12:37 ET

Sanofi Pasteur annonce des résultats encourageants pour l'essai de Phase II du candidat vaccin Clostridium difficile au congrès de l'ECCMID

- L'étude montre que le vaccin induit une réponse immunitaire contre les principales toxines et permet d'identifier le dosage pour les...

May 19, 2014, 08:00 ET

Sanofi Pasteur Announces Favorable Phase II Study Results for Investigational Clostridium difficile Vaccine at the American Society for Microbiology Meeting

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), presented Phase II trial (H-030-012) results for an investigational...

May 13, 2014, 08:00 ET

Jerome Bettis, Sanofi US and Allergy Foundation Launch Severe, Life-Threatening Allergies Quiz

Professional football icon Jerome Bettis, the Asthma and Allergy Foundation of America (AAFA) and Sanofi US, the makers of Auvi-Q®...

May 12, 2014, 10:28 ET
Veterans Advancing ALS/MND Team Wins Sanofi's Partners in Patient Health and North America Research & Development Hub Collaborate Innovate Challenge (PRNewsFoto/Sanofi)

Veterans Advancing ALS/MND Wins Sanofi US Innovation Challenge: Collaborate Innovate

 Sanofi US announced the winner of its second Innovation Challenge: Collaborate Innovate. The winner, Veterans Advancing ALS/MND, is a...

May 12, 2014, 08:19 ET

National Survey Reveals Mothers Are Unaware of the CDC Recommendations for Prevention of Meningococcal Meningitis, a Disease That Can Potentially Kill in 24 Hours

Although meningococcal meningitis is a rare but serious disease that can potentially take a life in 24 hours,1 a national survey revealed that more...